Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Debt to Equity (2019 - 2025)

Immunocore Holdings' Debt to Equity history spans 4 years, with the latest figure at $1.03 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 4.82% year-over-year to $1.03; the TTM value through Dec 2025 reached $1.03, down 4.82%, while the annual FY2025 figure was $1.03, 4.82% down from the prior year.
  • Debt to Equity for Q4 2025 was $1.03 at Immunocore Holdings, up from $0.99 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.22 in Q2 2024 and bottomed at $0.13 in Q4 2023.
  • The 4-year median for Debt to Equity is $1.03 (2025), against an average of $0.89.
  • The largest annual shift saw Debt to Equity soared 732.77% in 2024 before it dropped 17.27% in 2025.
  • A 4-year view of Debt to Equity shows it stood at $0.14 in 2022, then fell by 7.73% to $0.13 in 2023, then skyrocketed by 732.77% to $1.08 in 2024, then fell by 4.82% to $1.03 in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Debt to Equity are $1.03 (Q4 2025), $0.99 (Q3 2025), and $1.01 (Q2 2025).